MoonLake Immunotherapeutics (MLTX) stock
MLTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$11.25−0.48 (-4.09%)
Close on Nov 17, 2026Market cap $957.45MP/E –Yield –
MoonLake Immunotherapeutics pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
MoonLake Immunotherapeutics's pe ratio was 255.5× on Oct 31, 2022.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2022 | Oct 31, 2022 | 255.5× | – |
See a number that looks wrong?